Improving HIV prevention services for racially diverse women who use drugs
LOTUS: An mHealth Intervention to Improve HIV Prevention Service Engagement and Intersectional Stigma among Racially Diverse Women Who Use Drugs
This study is creating a helpful mobile app to support women of different backgrounds who use drugs, making it easier for them to access HIV prevention services and get the care they need.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10889958 on NIH RePORTER |
What this research studies
This research focuses on developing a mobile health (mHealth) intervention aimed at enhancing engagement with HIV prevention services among racially diverse women who use drugs. The project will utilize intersectionality theory to address the unique challenges faced by these women, including stigma and substance use. The intervention will be designed and tested through randomized controlled trials to ensure its effectiveness and feasibility in real-world settings. Participants will receive support and resources tailored to their specific needs, promoting better health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are racially diverse women who use drugs and are at risk for HIV.
Not a fit: Patients who do not identify as women or do not use drugs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to and engagement with HIV prevention services for vulnerable women, ultimately reducing HIV disparities.
How similar studies have performed: Previous research has shown success in using mobile health interventions to improve health outcomes in similar populations, indicating a promising approach.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Meyers-Pantele, Stephanie Alice — University of California, San Diego
- Study coordinator: Meyers-Pantele, Stephanie Alice
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.